The complement-inhibiting protein, protectin (CD59 antigen), is present and functionally active on glomerular epithelial cells
- PMID: 1704296
- PMCID: PMC1535243
- DOI: 10.1111/j.1365-2249.1991.tb05623.x
The complement-inhibiting protein, protectin (CD59 antigen), is present and functionally active on glomerular epithelial cells
Abstract
Protectin (CD59 antigen) is a 20-kD phosphatidyl-inositol-linked membrane protein that inhibits formation of the membrane attack complex (MAC) of complement on homologous cells. Although the antigen has been identified in a number of human tissues, until recently a functional role had been demonstrated only in circulating cells. Using immunofluorescence techniques we have shown the presence of protectin on human glomerular epithelial cells (GEC) in culture and on GEC, tubular epithelial cells and endothelial cells in frozen sections of normal human renal cortex. In addition, we present evidence that this protein functions in protection of GEC from homologous complement: cultured cells incubated with the Fab2 fragment of a monoclonal anti-protein antibody were markedly more susceptible to killing by homologous serum than were cells in the absence of Fab2 anti-protectin. These findings suggest that this protein may be important in the maintenance of glomerular integrity in vivo, and may be of relevance in certain renal diseases.
Similar articles
-
Immunolocalization and characterization of the rat analogue of human CD59 in kidney and glomerular cells.Immunology. 1993 Nov;80(3):439-44. Immunology. 1993. PMID: 7507093 Free PMC article.
-
Crry and CD59 regulate complement in rat glomerular epithelial cells and are inhibited by the nephritogenic antibody of passive Heymann nephritis.J Immunol. 1995 Apr 1;154(7):3437-43. J Immunol. 1995. PMID: 7534798
-
Human protectin (CD59), an 18-20-kD homologous complement restriction factor, does not restrict perforin-mediated lysis.J Exp Med. 1990 Jul 1;172(1):367-70. doi: 10.1084/jem.172.1.367. J Exp Med. 1990. PMID: 1694224 Free PMC article.
-
Antigenic targets in epimembranous glomerulonephritis. Experimental data and potential application in human pathology.Appl Pathol. 1989;7(2):85-98. Appl Pathol. 1989. PMID: 2567175 Review.
-
CD59: its role in complement regulation and potential for therapeutic use.Immunotechnology. 1995 Dec;1(3-4):157-68. doi: 10.1016/1380-2933(95)00018-6. Immunotechnology. 1995. PMID: 9373344 Review.
Cited by
-
Experimental membranous nephropathy redux.Am J Physiol Renal Physiol. 2005 Oct;289(4):F660-71. doi: 10.1152/ajprenal.00437.2004. Am J Physiol Renal Physiol. 2005. PMID: 16159900 Free PMC article. Review.
-
Membrane attack complex of complement and 20 kDa homologous restriction factor (CD59) in myocardial infarction.Virchows Arch. 1997 Apr;430(4):327-32. doi: 10.1007/BF01092756. Virchows Arch. 1997. PMID: 9134044
-
Immunolocalization and characterization of the rat analogue of human CD59 in kidney and glomerular cells.Immunology. 1993 Nov;80(3):439-44. Immunology. 1993. PMID: 7507093 Free PMC article.
-
Characterization of the membrane attack complex inhibitory protein CD59 antigen on human amniotic cells and in amniotic fluid.Immunology. 1992 Aug;76(4):541-7. Immunology. 1992. PMID: 1383132 Free PMC article.
-
Expression of CD59, a complement regulator protein and a second ligand of the CD2 molecule, and CD46 in normal and neoplastic colorectal epithelium.Br J Cancer. 1993 Nov;68(5):926-31. doi: 10.1038/bjc.1993.456. Br J Cancer. 1993. PMID: 7692919 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous